Daptomycin-Induced Eosinophilic Pneumonia: Eosinophil Elevation
Yes, eosinophil counts are frequently elevated in daptomycin-induced eosinophilic pneumonia, though peripheral eosinophilia is not always present and should not be relied upon to exclude the diagnosis.
Key Diagnostic Features
The FDA drug label explicitly warns that eosinophilic pneumonia has been reported with daptomycin use 1. The clinical presentation typically includes:
- Timing: Develops 2-4 weeks after starting daptomycin (though can occur earlier)
- Symptoms: Fever, dyspnea with hypoxic respiratory insufficiency
- Imaging: Diffuse pulmonary infiltrates or organizing pneumonia
- Laboratory findings: Variable eosinophilia
Eosinophil Count Patterns
Peripheral Blood Eosinophilia
Peripheral eosinophilia is common but not universal:
- Multiple case reports document peripheral eosinophilia ranging from 7-34% 2, 3, 4, 5, 6, 7
- One case demonstrated marked peripheral eosinophilia (34.1%) without pulmonary involvement 6
- Critical caveat: At least one case of confirmed DIEP presented with minimal peripheral eosinophilia 8, demonstrating that absence of peripheral eosinophilia does not exclude the diagnosis
Bronchoalveolar Lavage (BAL) Eosinophilia
BAL eosinophilia is the more definitive finding 9:
- BAL typically shows >25% eosinophils in confirmed cases 3, 5
- One case showed 9% BAL eosinophilia after corticosteroid exposure, which may have reduced the count 8
- BAL is recommended when clinical suspicion exists, as it provides more direct evidence of pulmonary eosinophilic inflammation
Clinical Algorithm for Suspected DIEP
When a patient on daptomycin develops new respiratory symptoms:
- Check peripheral eosinophil count - but do not exclude DIEP if normal
- Obtain chest imaging - look for bilateral ground-glass opacities or consolidations
- Consider BAL if diagnosis uncertain and patient stable enough for procedure
- Exclude infection - obtain respiratory cultures, but positive cultures do not rule out DIEP 2
- Discontinue daptomycin immediately if DIEP suspected 1
- Initiate systemic corticosteroids - recommended by FDA label 1
Important Clinical Pitfalls
Do not wait for peripheral eosinophilia to make the diagnosis. The temporal relationship with daptomycin exposure, compatible imaging findings, and exclusion of alternative diagnoses are more critical than the presence of peripheral eosinophilia 8.
Do not dismiss DIEP because respiratory cultures are positive. Critically ill patients may have concurrent infections, and positive cultures should not delay daptomycin discontinuation when DIEP is suspected 2.
Monitor patients receiving daptomycin for >2 weeks closely for new respiratory symptoms, as this is the typical window for DIEP development 1.
The diagnosis requires high clinical suspicion in the appropriate temporal context, with rapid improvement typically occurring within 24 hours of daptomycin withdrawal and corticosteroid initiation 2, 3, 7.